Moreover, the hypothesis that SVTs represent early signs of MPN might partly explain why MPN-SVT patients tend to be younger and exhibit lower JAK2 V617F allele burdens [47]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.